Last reviewed · How we verify

NCT07210905

Implementation of the 3-steps Assess-Advise-Refer Exercise (FitARise) Protocol as a Standard Practice in Cancer Care

Not yet recruiting NA Last updated 10 December 2025
What this trial tests

NA trial testing 3-step Assess-Advice-Refer in Exercise in 1,800 participants. Not yet recruiting.

Timeline
1 December 2025
Primary endpoint
2 February 2027
2 February 2028

Quick facts

Lead sponsorThe University of Hong Kong
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposehealth services research
Enrollment1,800
Start date1 December 2025
Primary completion2 February 2027
Estimated completion2 February 2028
Sites8 locations across Hong Kong

Drugs / interventions tested

Conditions studied

Sponsor

The University of Hong Kong

Who can join

18 and older, any sex, with Exercise or Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study proposes to evaluate the process and outcome of an implementation program designed to implement the American College of Sports Medicine (ACMS)-recommended exercise assessment, advice, and referral instruction as standard practices in routine cancer care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Exercise

Currently open trials in the same condition.

Other The University of Hong Kong trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07210905.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing